Earnings Feed
Start Free
CorMedix Inc.·4

Jan 2, 9:30 PM ET

DUNTON ALAN W 4

4 · CorMedix Inc. · Filed Jan 2, 2026

Insider Transaction Report

Form 4
Period: 2025-12-30
CorMedix Inc.CRMD
DUNTON ALAN W
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-30$4.03/sh+20,000$80,600→ 60,250 total
  • Sale

    Common Stock

    2025-12-30$13.00/sh−20,000$260,000→ 40,250 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2025-12-30−20,000→ 0 total
    Exercise: $4.03Exp: 2032-02-22→ Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]These options were granted on 2/22/2022. These options are fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary